Bladder Morphology Using 2 Different Catheter Designs

NCT03108079 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-04-12

No results posted yet for this study

Summary

Demonstrate and compare the 3D morphology of the bladder wall in full and drained states with 2 different kinds of bladder catheters in place. (Foley Catheter vs. Cystosure Catheter)

Conditions

  • Urologic Injuries
  • Urologic Diseases
  • Bladder Infection
  • Urinary Tract Infections
  • Mucosal Inflammation
  • Mucosal Infection
  • Bladder Injury
  • Catheter-Related Infections
  • Catheter Complications
  • Catheter; Infection (Indwelling Catheter)
  • Pelvic Floor Disorders
  • Urinary Incontinence

Interventions

DEVICE

Cystosure Urinary Access System

1. Demonstrate the 3D bladder wall anatomy with 300 cc of fluid infused with each of the following bladder drainage mechanisms 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 2. Compare the fluid flow pattern during bladder drainage for 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 3. Compare the 3D bladder wall anatomy after emptying the bladder with 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B)

DEVICE

Foley Catheter

1. Demonstrate the 3D bladder wall anatomy with 300 cc of fluid infused with each of the following bladder drainage mechanisms 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 2. Compare the fluid flow pattern during bladder drainage for 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B) 3. Compare the 3D bladder wall anatomy after emptying the bladder with 1. The traditional Foley catheter (Catheter A) 2. The novel FDA approved Cystosure catheter (Catheter B)

Sponsors & Collaborators

  • Cystosure

    collaborator UNKNOWN
  • Innovative Research Inc.

    collaborator UNKNOWN
  • The Pelvic Floor Institute

    lead OTHER

Principal Investigators

  • Lennox Hoyte, MD, MSEECS · The Pelvic Floor Institute

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-30
Primary Completion
2017-05-31
Completion
2017-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03108079 on ClinicalTrials.gov